VERTEX PHARMACEUTICALS INC / MA Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2019 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2024 was $933M.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $933M Sep 30, 2024 10-Q 2024-11-05
Q4 2023 $54.4M -$8.8M -13.9% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $63.2M -$1.8M -2.77% Dec 31, 2022 10-K 2023-02-10
Q4 2021 $65M -$8.37M -11.4% Dec 31, 2021 10-K 2022-02-09
Q4 2020 $73.4M +$53.9M +276% Dec 31, 2020 10-K 2021-02-11
Q4 2019 $19.5M Dec 31, 2019 10-K 2020-02-13
Q3 2019 $16.8M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $17.1M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $17.9M Mar 31, 2019 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.